Request Demo
Last update 07 Sep 2026
HemaCell Biotechnology Inc.
Last update 07 Sep 2026
Overview
Tags
Hemic and Lymphatic Diseases
Congenital Disorders
Other Diseases
Induced pluripotent stem cells (iPSC)
Hematopoietic stem cell therapy
Cell therapy
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20254728
一项评价脐带血巨核细胞注射液（XJ-MK-002注射液）对肿瘤治疗引起的血小板减少（CTIT）患者的安全性、耐受性和初步有效性的剂量递增I期临床研究
[Translation] A dose-escalation phase I clinical study evaluating the safety, tolerability, and preliminary efficacy of cord blood megakaryocyte injection (XJ-MK-002 injection) in patients with cancer-induced thrombocytopenia (CTIT).
CTR20262345
一项评价脐带血巨核细胞注射液（XJ-MK-002注射液）对再生障碍性贫血（AA）所致血小板减少症患者的安全性、耐受性和初步有效性的剂量递增I期临床研究
[Translation] A dose-escalation phase I clinical study evaluating the safety, tolerability, and preliminary efficacy of umbilical cord blood megakaryocyte injection (XJ-MK-002 injection) in patients with thrombocytopenia caused by aplastic anemia (AA).
100 Clinical Results associated with HemaCell Biotechnology Inc.
Login to view more data
Login to view more data
100 Deals associated with HemaCell Biotechnology Inc.
Login to view more data
100 Translational Medicine associated with HemaCell Biotechnology Inc.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 11 Sep 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
9
6
Preclinical
IND Application
1
1
IND Approval
Phase 1
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free